药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alfacalcidol
Tegafur
The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Tegafur.
Alfacalcidol
Uracil
The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Uracil.
Alfacalcidol
5-fluorouridine
The risk or severity of adverse effects can be increased when Levomefolic acid is combined with 5-fluorouridine.
Alfacalcidol
Glucarpidase
The serum concentration of the active metabolites of Levomefolic acid can be reduced when Levomefolic acid is used in combination with Glucarpidase resulting in a loss in efficacy.
19-norandrostenedione
Satralizumab
The serum concentration of Tocopherol can be decreased when it is combined with Satralizumab.
19-norandrostenedione
Abametapir
The serum concentration of Tocopherol can be increased when it is combined with Abametapir.
19-norandrostenedione
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Tocopherol.
19-norandrostenedione
Cenobamate
The serum concentration of Tocopherol can be decreased when it is combined with Cenobamate.
19-norandrostenedione
Metreleptin
The metabolism of Tocopherol can be increased when combined with Metreleptin.
19-norandrostenedione
Efonidipine
Efonidipine may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Indisulam
Indisulam may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Potassium
Potassium may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Bromotheophylline
Bromotheophylline may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Epitizide
Epitizide may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Xipamide
Xipamide may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Muzolimine
Muzolimine may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Clopamide
Clopamide may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Fenquizone
Fenquizone may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Clofenamide
Clofenamide may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.
19-norandrostenedione
Clorexolone
Clorexolone may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.